LONDON, June 21 (Reuters) - Shire Plc said on Thursday the U.S. Food and Drug Administration (FDA) intended to approve Intuniv, its extended-release, non-stimulant treatment for attention deficit ...
Alembic is launching Guanfacine Extended-Release tablets in dosage strengths of 1 mg, 2 mg, 3 mg and 4 mg. The product is the generic of Takeda’s Intuniv Extended-Release tablets. Guanfacine ...
A federal judge on Tuesday certified a class of drug distributors and other companies who say they paid inflated prices for Shire PLC's ADHD drug Intuniv due to an improper patent lawsuit settlement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results